Recently Added
News
Upending NSCLC Survival Rates with New Care Paradigms
For years, researcher-clinician Hossein Borghaei, DO, MS, Chief, Thoracic Medical Oncology, Fox Chase Cancer Center, has been at the forefront of global exploration into the genetic, proteomics, and cellular landscape of non-small cell ...
Document
DEPARTMENT OF HEMATOLOGY/ONCOLOGY THORACIC CANCERS CLINICAL TRIALS
For general questions about clinical trials, call 215-214-1515 or visit FoxChase.org/ClinicalTrials.
News
Comprehensive Care That Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and Survivorship
News
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital ...
News
TAS1440 +/- All-Trans Retinoic Acid (ATRA) in Relapsed/Refractory AML
A first of its kind, Phase 1 multi-center study for Relapsed or Refractory Acute Myeloid Leukemia using an investigational drug TAS1440 by itself, and in combination with All-Trans Retinoic Acid (ATRA).
Document
Temple – Fox Chase Thoracic Surgery
The thoracic surgery program at Temple Health provides high-quality surgical care for a wide range of conditions, from benign to thoracic malignancies in the lungs, esophagus, airways, pleura, or chest wall.
News
Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer
To further evaluate the use of immunotherapy for these patients with NSCLC, Treat is serving as a primary investigator in a nationwide Phase II, double-arm, randomized clinical trial of treatment-naïve never smokers without the EGFR driver ...
News
Pulsed Low-Dose-Rate Radiation Offers New Treatment Option for Variety of Solid Tumors
Clinicians at Fox Chase Cancer Center are exploring how an established radiation technique—pulsed low-dose-rate radiation (PLDR)—might benefit patients with a variety of solid tumors.
News
CivaSheet® for precise radiation delivery for pancreatic cancer
CivaSheet®?is an FDA-approved Pd-103 brachytherapy planar radiation source that is radioactive on only one side. It is designed to safely deliver high doses of radiation to precisely targeted areas.
